Efficient and ligand-dependent regulated erythropoietin production by naked DNA injection and in vivo electroporation
- 1 October 2001
- journal article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 38 (4) , S50-S53
- https://doi.org/10.1053/ajkd.2001.27398
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Prolonged Expression and Effective Readministration of Erythropoietin Delivered with a Fully Deleted Adenoviral VectorHuman Gene Therapy, 2000
- Gene therapy for renal anemia in mice with polycystic kidney using an adenovirus vector encoding the human erythropoietin geneKidney International, 1999
- Long-term control of erythropoietin secretion by doxycycline in mice transplanted with engineered primary myoblastsNature Medicine, 1997
- Immune responses to transgene–encoded proteins limit the stability of gene expression after injection of replication–defective adenovirus vectorsNature Medicine, 1996
- Gene therapy for long-term expression of erythropoietin in rats.Proceedings of the National Academy of Sciences, 1995
- Stimulation of erythropoiesis by in vivo gene therapy: physiologic consequences of transfer of the human erythropoietin gene to experimental animals using an adenovirus vectorBlood, 1994
- Retrovirus-mediated transfer of the erythropoietin gene in hematopoietic cells improves the erythrocyte phenotype in murine beta- thalassemiaBlood, 1994
- ErythropoietinArchives of internal medicine (1960), 1993
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- Anemia induces accumulation of erythropoietin mRNA in the kidney and liver.Molecular and Cellular Biology, 1986